Minnesota Drugmaker Cited for Cleaning Deficiencies

Drug Industry Daily
A A
The FDA hit Minnesota generic drug manufacturer Upsher Smith Laboratories with a Form 483 over cleaning and batch production violations at its Plymouth facility.

To View This Article:

Login

Subscribe To Drug Industry Daily